Business Wire

PUMA

24.3.2024 09:01:26 CET | Business Wire | Press release

Share
PUMA Reveals Jamaican Olympic Kit in Spectacular Showcase of Speed at Prestigious ISSA Boys & Girls Championships

Globally renowned sports brand, PUMA, proudly unveiled the highly anticipated Jamaican Olympic Association kits during an unmissable showcase of speed at the ISSA Boys & Girls Championships in Kingston, Jamaica.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240324802511/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Sports company PUMA unveiled the Jamaican Olympic Association kits at the ISSA Boys & Girls Championships in Kingston, Jamaica. (Pictured: Shanieka Ricketts) (Photo: Business Wire)

The reveal, at the Jamaica National Stadium, came in front of more than 25,000 track enthusiasts from across the country, all gathering to feast their eyes on the future of Jamaican track & field. It served as the perfect platform to showcase the cutting-edge apparel that will adorn the fastest athletes on the planet this summer in Paris – many of whom competed at this event in their teenage years.

Jamaica’s most prestigious athletes took centre stage for the grand reveal, including the likes of double, double Olympic Champion, Elaine Thompson-Herah; the fastest woman alive at the 200 meters, Shericka Jackson; reigning Olympic Champion at the 110m hurdles Hansle Parchment; the second fastest man of all-time, Yohan Blake; former 100m World Record holder, Asafa Powell; World U-20 Triple Jump Champion Jaydon Hibbert; Rushell Clayton, Ackeem Blake and many more. They were joined side-by-side on the track by young athletes from PUMA sponsored high schools.

The ISSA Boys & Girls Championships, often referred to as "Champs," has gained immense popularity and recognition for its ability to showcase young Jamaican talent who have gone on to achieve greatness on both the domestic and international stage. The Championships not only celebrate sporting excellence but also serve as a symbol of unity, passion and pride for the Jamaican community.

"Champs is the beating heart of Jamaica. For decades, it has produced an unimaginable number of Olympians, World Champions and World Record holders, who themselves have created some of the most memorable moments in sports history. Tonight, here in Kingston, we created another,” said PUMA's Chief Executive Officer, Arne Freundt.

The new designs represent a perfect harmony of speed and fashion, reflective of the symbiotic relationship between these two giants of track & field.

Rooted in elite performance, they have been designed to evoke speed with cut lines strategically placed to accentuate the physique of the athletes whilst also providing a showstopping visual via Warpspeed graphics that emphasise the beauty of an athlete in motion. Engineered jacquard fabric is ergonomically shaped to contour the back muscles for heat reduction and breathability, with thermoadapt technology regulating body temperature to enable optimum performance.

“In their truest form these kits are an expression of speed. Speed has always been PUMA’s vantage point. It is what enables us to see the game differently, challenge convention and create moments that will live with us forever. We can’t wait to experience more in Paris this summer,” added Arne.

Maria Valdes, Chief Product Officer at PUMA, commented: “What makes these kits special is how closely they have been created in collaboration with our athletes. They are more than just a kit – they are a statement of the collective ambition shared between PUMA and Jamaica. They are a symbol of pride for the PUMA family, and we hope that they become a symbol of pride for Jamaicans this summer and long into the future.”

To find out more about PUMA follow @pumarunning on Instagram.

PUMA

PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For more than 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 21,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240324802511/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye